Development of novel anti-inflammatory strains to counterbalance dysbiosis in inflammatory bowel disorders

The link between the intestinal microbiota and gut inflammation in IBD in humans and NE in poultry supports selective manipulation of the microbiota composition as a therapeutic strategy. Butyrate producing bacteria have significant anti-inflammatory potential due to production of butyrate and other extracellular compounds. The aim is to investigate anti-inflammatory properties of newly isolated butyrate producing bacteria to use for treatment of IBD and NE.